AARTI DRUGS share price has plunged 4% and is presently trading at Rs 506.0.
Meanwhile, the BSE HEALTHCARE index is at 40,224.5 (up 0.1%).
Among the top losers in the BSE HEALTHCARE index today are SUVEN PHARMACEUTICALS (down 3.6%) and Abbott India (down 2.2%).
FDC (up 5.8%) and ERIS LIFESCIENCES (up 2.8%) are among the top gainers today.
Over the last one year, AARTI DRUGS has moved down from Rs 608.5 to Rs 506.0, registering a loss of Rs 102.5 (down 16.8%).
On the other hand, the BSE HEALTHCARE index has moved up from 26,901.6 to 40,224.5, registering a gain of 49.5% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Cadila Healthcare (up 99.2%), Lupin (up 98.2%) and Jubilant Pharmova (up 96.1%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 81,328.5 .
The top losers among the BSE Sensex today are Titan (down 2.6%) and Bharti Airtel (down 2.0%). The most traded stocks in the BSE Sensex are Tata Steel and SBI.
In the meantime, NSE Nifty is at 24,831.2 . Titan and Bharti Airtel are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 66,355.7 to 81,328.5, registering a gain of 14,972.8 points (up 22.6%).
AARTI DRUGS net profit fell 30.6% YoY to Rs 333 million for the quarter ended June 2024, compared to a profit of Rs 480 million a year ago. Net sales declined 16.0% to Rs 5,553 million during the period as against Rs 6,611 million in April-June 2023.
For the year ended March 2023, AARTI DRUGS reported 18.8% decrease in net profit to Rs 1,664 million compared to net profit of Rs 2,050 million during FY22. Revenue of the company grew 9.1% to Rs 27,161 million during FY23.
The current Price to earnings ratio of AARTI DRUGS, based on rolling 12 month earnings, stands at 29.7.
Equitymaster requests your view! Post a comment on "AARTI DRUGS Plunges 4%; BSE HEALTHCARE Index Up 0.1%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!